Tumor necrosis factor α and toxicology

Critical Reviews in Toxicology

Volumn 29, Issue 5, 1999, Pages 491-511

  Luster, Michael I ^a   Simeonova, Petia P ^a   Gallucci, Randle ^a   Matheson, Joanna ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Proinflammatory cytokines and chemical damage; Tumor necrosis factor and toxicity

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DAMAGE; CELL REGENERATION; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY; GENE EXPRESSION; HOMEOSTASIS; HUMAN; KIDNEY; LIVER; LUNG; MOLECULAR BIOLOGY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; SHOCK; TOXICOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; HAZARDOUS SUBSTANCES; HUMANS; KIDNEY DISEASES; LIVER DISEASES; LUNG DISEASES; SKIN DISEASES; TOXICOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 0032830611     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408449991349258     Document Type: Article

References (162)

1. Vassali, P., The pathophysiology of tumor necrosis factor, Ann. Rev. Immunol., 1992; 10: 411-52.
2. Bazzoni, F. and Beutler, B., Seminars in medicine of the Beth Israel Hospital, Boston: the tumor necrosis factor ligand and receptor families, N. Engl. J. Med., 1996; 334: 1717-25.
3. Aggarwal, B. B. and Natarajan, K., Tumor necrosis factors: developments during the last decade, Eur. Cytokine Network, 1996; 7: 93-124.
4. Kriegler, M., Perez, C., DeFay, K., Albert, I., and Lu, S. D., A novel form of TNF/cahectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF, Cell, 1988, 53: 45-53.
5. Beyaert, R. and Fiers, W., Tumor necrosis factor and lymphotoxin, Cytokines, 1998; 24: 335-59.
6. Schook, L. B. and Laskin, D. L., Xenobiotics and Inflammation, Academic Press, San Diego, 1994.
7. Darnay, B. G. and Aggarwal, B. B., Early events in TNF signaling: a story of associations and dissociations, J. Leuk. Biol., 1997; 61: 55966.
8. Miyamato, S., Maki, M., Schmitt, M. J., Hatanaka, M., and Verma, I. M., Tumor necrosis factor α induced phosphorylation of IκBα is a signal for its degradation but not association from NF-αB, Proc. Natl. Acad. Sci., 1994; 91: 12740-4.
9. Zhang, X. M., Weber, I., and Chen, M. J., Site-directed mutational analysis of human tumor necrosis factor α receptor binding site and structure-functional relationship, J. Biol. Chem., 1992, 267: 24069-75.
10. Schmid, D. S., Tite, J. P., and Ruddle, N. H., DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell clones and cell-free lymphotoxin-containing supernatant, Proc. Natl. Acad. Sci. USA, 1986, 83: 1881-7.
11. Zhang, M. and Tracey, K. J., Tumor necrosis factor, in The Cytokine Handbook, Academic Press, San Diego, 1998, 19: 517-48.
12. Milenkovic, L., Rettori, V., Snyder, G. D., Beutler, B., and McCann, S. M., Cachectin alters anterior pituitary hormone, release by a direct action in vitro, Proc. Natl. Acad. Sci. USA, 1989, 86: 2418-22.
13. Sherry, B. and Cerami, A., Cachectia/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses, J. Cell Biol., 1988, 107: 1269-77.
14. Brenner, D. A., O'Hara, M., Angel, P., Chojkier, M., and Karin, M., Prolonged activation of jun and collagenase genes by tumor necrosis factor-α, Nature, 1989, 337: 661-3.
15. Hoffman, M. and Weinberg, J. B., Tumor necrosis factor-α induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages, J. Leukocyte Biol, 1987, 42: 704-7.
16. Jaesche, H., Smith, C. W., Clemens, M. G., Ganey, P. E., and Roth, R. A., Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils, Toxicol. Appl. Pharmacol., 1996; 139: 213-26.
17. Gallucci, R. M., Simeonova, P. P, Toriumi, W., and Luster, M. I., Tumor necrosis factor-α modulates transforming growth factor-alpha in murine regenerating liver and isolated hepatocytes, 1998, submitted.
18. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B., An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. USA, 1975, 72: 3666-70.
19. Czaja, M. J., Xu, J., Ju, Y., Alt, E., and Schmiedeberg, P., Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration, Hepatology, 1994; 19: 1282-9.
20. Barriault, C., Petit, J. L., Gascon-Barre, M., Huet, P. M., Yousef, I. M., and Tuchweber, B., Effect of phalloidin on cholestasis, hemodynamics, and microcirculation in isolated perfused rat liver, Hepatology, 1996; 23: 294-302.
21. Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., and Thurman, R. G., Antibiotics prevent liver injury in rats following longterm exposure to ethanol, Gastroenterology, 1995; 108: 218-24.
22. Laskin, D. L., Gardner, C. R., Price, V. F., and Jollow, D. J., Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen, Hepatology, 1995; 21: 1045-50.
23. Ishiyama, H., Ogino, K., and Hobara, T., Role of Kupffer cells in rat liver injury induced by diethyldithiocarbamate, Eur. J. Pharmacol., 1995; 292: 135-41.
24. Ewards, M. J., Keller, B. J., Kauffman, F. C., and Thurman, R. G., The involvement of Kupffer cells in carbon tetrachloride toxicity, Toxicol. Appl. Pharmacol., 1993; 119: 275-9.
25. Andus, T., Bauer, J., and Gerok, W., Effects of cytokines on the liver, Hepatology, 1991; 13: 364-75.
26. Feingold, K. R., and Grunfeld, C., Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo, J. Clin. Invest., 1987; 80: 184-90.
27. Tilg, H., The role of cytokines in the patho-physiology of chronic liver diseases, Int. J. Clin. Lab Res., 1993; 23: 179-85.
28. 28. Bird, G. L., Sheron, N., Goka, A. K., Alexander, G. J., and Williams, R. S., Increased plasma tumor necrosis factor in severe alcoholic hepatitis, Ann. Intern. Med., 1990; 112: 917-20.
29. Muto, Y., Nouri-Aria, K. T., Meager, A., Alexander, G. J., Eddleston, A. L., and Williams, R., Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure, Lancet, 1988; 2: 72-4.
30. Czaja, M. J., Flanders, K. C., Biempica, L., Klein, C., Zern, M. A., and Weiner, F. R., Expression of tumor necrosis factor-alpha and transforming growth factor-β 1 in acute liver injury, Growth Factors, 1989; 1: 219-26.
31. Kayama, F., Yoshida, T., Elwell, M. R., and Luster, M. I., Role of tumor necrosis factor-α in cadmium-induced hepatotoxicity, Toxicol. Appl. Pharmacol., 1995; 131: 224-34.
32. Blazka, M. E., Wilmer, J. L., Holladay, S. D., Wilson, R. E., and Luster, M. I., Role of proinflammatory cytokines in acetaminophen hepatotoxicity, Toxicol. Appl. Pharmacol., 1995; 133: 43-52.
33. Schook, L. B., Lockwood, J. F., Yang, S. D., and Myers, M. J., Dimethylnitrosamine (DMN)-induced IL-1β, TNF-α, and IL-6 inflammatory cytokine expression, Toxicol. Appl. Pharmacol., 1992; 116: 110-6.
34. Iimuro, Y., Gallucci, R. M., Luster, M. I., Kono, H., and Thurman, R. G., Antibodies to tumor necrosis factor attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat, Hepatology, 1997; 26: 1530-7.
35. Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., Tannahill, C. L., Solorzano, C. C., Norman, J., Denham, W., Clare-Salzler, M., MacKay, S. L., and Moldawer, L. L., Disparate roles for TNF- and Fas ligand in concanavalin A-α induced hepatitis, J. Immunol., 1998; 160: 4082-9.
36. Dugyala, R. R., Sharma, R. P., Tsunoda, M., and Riley, R. T., Tumor necrosis factor-α as a contributor in fumonisin B1 toxicity, J. Pharmacol. Exp. Ther., 1998; 285: 317-24.
37. Laskin, D. L. and Pendino, K. J., Macrophages and inflammatory mediators in tissue injury, Ann. Rev. Pharmacol. Toxicol., 1995; 35; 655-77.
38. Czaja, M. J., Xu, J., and Alt, E., Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor, Gastroenterology, 1995; 108: 1849-54.
39. Bruccoleri, A., Gallucci, R., Germolec, D. R., Blackshear, P., Simeonova, P., Thurman, R. G., and Luster, M. I., Induction of early-immediate genes by tumor necrosis factor contribute to liver repair following chemical-induced hepatotoxicity, Hepatology, 1997; 25: 133-41.
40. Roth, R. A., Harkema, J. R., Pestka, J. P., and Ganey, P. E., Is exposure to bacterial endotoxin a detriment of susceptibility to intoxication from xenobiotic agents?, Toxicol. Appl. Pharmacol., 1997; 147: 300-11.
41. Ray, S. D., Kamendulis, L. M., Gurule, M. W., Yorkin, R. D., and Corcoran, G. B., Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen, FASEB J., 1993; 7: 453-63.
42. Ray, S. D., Sorge, C. L., Kamendulis, L. M., and Corcoran, G. B., Ca(++)-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: effects of Ca(++)-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice, J. Pharmacol. Exp. Ther., 1992; 263: 387-94.
43. Goldin, R. D., Hunt, N. C., Clark, J, and Wickramasinghe, S. N., Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes, J. Pathol., 1993; 171: 73-6.
44. Habeebu, S. S., Liu, J., and Klaassen, C. D., Cadmium-induced apoptosis in mouse liver, Toxicol. Appl. Pharmacol., 1998; 149: 203-9.
45. Reid, T. R., Torti, F. M., and Ringold, G. M., Evidence for two mechanisms by which tumor necrosis factor kills cells, J. Biol. Chem., 1989; 264: 4583-9.
46. Leist, M., Gantner, F., Bohlinger, I., Germann, P. G., Tiegs, G., and Wendel, A., Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest, J. Immunol., 1994; 153: 1778-88.
47. Leist, M., Gantner, F., Naumann, H., Bluethmann, H., Vogt, K., Brigelius-Flohe, R., Nicotera, P., Volk, H. D., and Wendel, A., Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins, Gastroenterology, 1997; 112: 923-34.
48. Feingold, K. R., Soued, M., and Grunfeld, C., Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats, Biochem. Biophys. Res. Commun., 1988; 153: 576-82.
49. Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J., and Diehl, A. M., Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy, Am. J. Physiol., 1992; 263: G579-85.
50. Satoh, M. and Yamazaki, M., Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor-β and interleukin-6, J. Cell Physiol., 1992; 150: 134-9.
51. Shinozuka, H., Ohmura, T., Katyal, S. L., Zedda, A. I., Ledda-Columbano, G. M., and Columbano, A., Possible roles of non-parenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor-β, Hepatology, 1996; 23: 1572-7.
52. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., and Taub, R., Liver failure and defective hepatocyte regeneration in intedeukin-6-deficient mice, Science, 1996; 274: 1379-83.
53. Yamada, Y., Kirillova, I., Peschon, J. J., and Fausto, N., Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor, Proc. Natl. Acad. Sci. USA, 1997; 94: 1441-6.
54. Shinozuka, H., Kubo, Y., Katyal, S. L., Coni, P., Ledda-Columbano, G. M., Columbano, A., and Nakamura, T., Roles of growth factors and of tumor necrosis factor-α on liver cell proliferation induced in rats by lead nitrate, Lab Invest., 1994; 71: 35-41.
55. Ledda-Columbano, G. M., Columbano, A., Cannas, A., Simbula, G., Okita, K., Kayano, K., Kubo, Y., Katyal, S. L., and Shinozuka, H., Dexamethasone inhibits induction of liver tumor necrosis factor-mRNA and liver growth induced by lead nitrate and ethylene dibromide, Am. J. Pathol., 1994; 145: 951-8.
56. Rose, M. L., Germolec, D. R., Schoonhoven, R., and Thurman, R. G., Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators, Carcinogenesis, 1997; 18: 1453-6.
57. Bojes, H. K., Germolec, D. R., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M. I., and Thurman, R. G., Antibodies to tumor necrosis factor prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643, Carcinogenesis, 1997; 18: 669-74.
58. Raj, R. M., Zhang, J. X., Clemens, M. G., and Diehl, A. M., Gadolinium chloride alters the acinar distribution of phagocytosis and balance between pro- and anti-inflammatory cytokines, Shock, 1996; 6: 243-7
59. Rai, R. M., Loffreda, S., Karp, C. L., Yang, S. Q., Lin, H. Z., and Diehl, A. M., Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor-α messenger RNA in the regenerating rat liver, Hepatology, 1997; 25: 889-95.
60. Rotter, B. A., Prelusky, D. B., and Pestka, J. J., Toxicology of deoxynivalenol (vomitoxin), J. Toxicol. Environ. Hlth., 1996; 48: 1-34.
61. Azcma-Olivera, J. I., Ouyang, Y., Murtha, J., Chu, F. S., and Pestka, J. J., Induction of cytokine mRNAs in mice after oral exposure to the trichothecene v-(deoxyniwalenol): relationship to toxin distribution and protein synthesis inhibition, Toxicol. Appl. Pharmacol., 1995; 133: 109-20.
62. Ideura, T., Yoshimura, A., Shirai, M., Taira, T., and Koshikawa, S., Endotoxin-induced acute tubular necrosis in cirrhotic rats, Scand. J. Urol. Nephrol., 1993; 27: 433-9.
63. Nagaike, M., Hirao, S., Tajima, H., Noji, S., Taniguchi, S., Matsumoto, K., and Nakamura, T., Renotropic functions of human growth factor in renal regeneration after unilateral nephrectomy, J. Biol. Chem., 1991; 266: 22781-4.
64. Sedor, J. R., Interleukin-1: a master cytokine in the renal response to injury, in Molecular Nephrology: Kidney Function in Health and Disease, Marcek Dekker, New York, 1995; 631-652.
65. Ostendorf, T., Burg, M., and Floege, J., Cytokines and glomerular injury, Kid. Blood Pressure Res., 1996; 19: 281-9.
66. Baud, L. and Ardaillou, R., Tumor necrosis factor in renal injury, Mineral Elect. Metabol., 1995; 21: 336-41.
67. Bigazzi, P. E., Autoimmunity and heavy metals, Lupus, 1994; 3: 449-453.
68. Kayama, F., Yoshida, T., Elwell, M. R., and Luster, M. I., Cadmium-induced renal damage and proinflammatory cytokines: possible role of IL-6 in tubular epithelial cell regeneration, Toxicol. Appl. Pharmacol., 1995; 134: 26-34.
69. Karkar, A. M., Smith, J., Tam, F. W. K., Pusey, C. D., and Rees, A. J., Abrogation of glomerular injury in nephrotic nephritis by continuous infusion of IL-6, Kid. Int., 1997; 52: 1313-20.
70. Gomez-Chiarri, M., Ortiz, A., Gonzalez-Cuadrado, S., Seron, D., Emancipator, S., Hamilton, T. A., Barat, A., Plaza, J. J., Gonzalez, E., and Egido, J., Interferon-inducible protein-10 is highly expressed in rats with experimental nephrosis, Am. J. Pathol., 1996; 148: 301-11.
71. Jones, C. L., Buch, S., Post, M., McCulloch, L., Liu, E., and Eddy, A. A., Pathogenesis of interstitial fibrosis in chronic puromycin aminonucleoside nephrosis, Kid. Int., 1991; 40: 1020-31.
72. Breder, C. D., Tsujimoto, M., Terano, Y., Scott, D. W., and Saper, C. B., Distribution and characterization of tumor necrosis factorα-like immunoreactivity in the murine central nervous system, J. Comp. Neurol., 1993; 337: 543-67.
73. Righi, M., Mori, L., de Libero, G., Sironi, M., Biondi, A., Mantovani, A., Donini, D. S., and Castagnoli, P. R., Monokine production by microglial cell clones, Eur. J. Immunol., 1989; 19: 1443-8.
74. Breder, C. D., Hazuka, C., Ghayur, T., Klug, C., Huginin, M., Yasuda, K., Teng, M., and Saper, C. B., Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration, Proc. Natl. Acad, Sci. U.S.A., 1994; 91: 11393-7.
75. Ignatowski, T. A., Noble, B. K., Wright, J. R., Gorfien, J. L., Heffner, R. R., and Spengler, R. N., Neuronal-associated tumor necrosis factor: its role in noradrenergic functioning and modification of its expression following antidepressant drug administration, J. Neuroimmunol. 1997; 79: 84-90.
76. Gahring, L. C., Carlson, N. G., Kulmar, R. A., and Rogers, S. W., Neuronal expression of tumor necrosis factor-α in the murine brain, Neuroimmunomodulation, 1996; 3: 289-303.
77. Selmaj, K. and Raine, S., Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro, Ann. Neurol., 1988; 23: 339-46.
78. Zajicek, J. P., Wing, M., Scolding, N. J., and Compton, H., Interactions between oligodendrocytes and microglia adherence and killing, Brain, 1992; 115: 1611-31.
79. Chakraborty, G., Ziemba, S., Drivas, A., and Ledeen, R. W., Myelin contains neutral sphyngomyelinase activity that is stimulated by tumor necrosis factor-α, J. Neurosci. Res., 1997; 50: 466-76.
80. Lavi, E., Suzumura, A., Murasko, D. M., Murray, E. M., Silberger, D. H., and Weiss, S. R., Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes, J. Neuroimmunol., 1988; 18: 245-53.
81. Vidovic, M., Sparacio, S. M., Elovitz, M., and Benveniste, E. N., Induction and regulation of class II MHC mRNA expression in astrocytes by IFN-γ and TNF-α, J. Neuroimmunol., 1990; 30: 189-200.
82. Selmaj, K. W., Farooq, M., Norton, W. T., Raine, C. S., and Brosnan, C. F., Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor, J. Immunol. 1990; 144: 129-35.
83. Brian, J. E. and Faraci, F. M., Tumor necrosis factor - induced dilation of cerebral arterioles, Stroke, 1998; 29: 509-15.
84. Fang, J., Wang, Y., and Krueger, J. M., Mice lacking the TNF55 kDa receptor and are involved in physiological sleep regulation fail to sleep more after TNFα treatment, J. Neurosci., 1996; 17: 5949-55.
85. Ruddle, N. H., Bergman, C.M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., and Clark, R. B., An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis, J. Exp. Med., 1990; 172: 1193-200.
86. Selmaj, K., Papierz, W., Glabinski, A., and Kohno, T., Prevention of chromic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor, J. Neuroimmunol., 1995; 56: 135-41.
87. Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G., and Kollias, G., Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α, Proc. Natl. Acad. Sci. USA, 1995; 92: 11294-8.
88. Akassoglou, K., Probert, L., Kontogeorgos, G., and Kollias, G., Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice, J. Immunol., 1997; 158: 438-45.
89. Lucas, R., Juillard, P., Decoster, E., Redard, M., Burger, D., Donati, Y., Giroud, C., Monso-Hinard, C., De Kesel, T., Buurman, W. A., Moore, M. W., Dayer, J. M., Fiers, W., Bluethmann, H, and Grau, G. E., Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria, Eur. J. Immunol., 1997; 27: 1719-25.
90. Fillit, H., Ding, W. H., Buee, L., Kalman, J., Alstiel, L., Lawlor, B., and Wolf-Klein, G., Elevated circulating tumor necrosis factor levels in Alzheimer's disease, Neurosci. Lett., 1991; 129: 318-20.
91. Ilyin, S. E. and Plata-Salaman, C. R., HIV-1 envelope glycoprotein 120 regulates brain IL-1 system and TNF-α mRNAs in vivo, Brain Res. Bull., 1997; 44: 67-73.
92. Lavine, S. D., Hofman, F. M., and Zlokovic, B. V., Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury, J. Cerebral Blood Flow Metabol., 1998; 18: 52-8.
93. Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., and Mattson, M. P., Altered neuronal and microglial responses to exitotoxic and ischemic brain injury in mice lacking TNF receptors, Nature Med., 1996; 2: 788-94.
94. Maier, W. E., Brown, H. W., Tilson, H. A., Luster, M. I., and Harry, G. J., Trimethyltin increases interleukin (IL)-1α, IL-6 and tumor necrosis factor-α mRNA levels in rat hippocampus, J. Neuroimmunol., 1995; 59: 65-75.
95. Maier, W. E., Bartenbach, M. J., Brown, H. W., Tilson, H. A., and Harry, G. J., Induction of tumor necrosis factor alpha in cultured glial cella by trimethyltin, Neurochem. Int., 1997; 30: 385-92.
96. Vivani, B., Corsini, E., Galli, C. L., and Marinovich, M., Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-α, Toxicol. Appl. Pharmacol., 1998; 150: 271-6.
97. 1 mRNA expression in acute lung inflammation, Am. J. Respir. Cell Mol. Biol., 1994; 10: 148-53.
98. Bonfield, T. L., Panuska, J. R., Konstan, M. W., Hilliard, K. A., Hilliard, J. B., Ghnaim, H., Berger, M., Inflammatory cytokines in cystic fibrosis lungs, Am. J. Respir. Crit. Care Med., 1995; 152: 2111-8.
99. Kasahara, K., Kobayashi, K., Shikama, Y., Yoneya, I., Kaga, S., Hashimoto, M., Odagiri, T., Soejima, K., Ide, H., Takahasi, T., and Yoshida, T., The role of monokines in granuloma formation in mice: the ability of interleukin-1 and tumor necrosis factor-α to induce lung granulomas, Clin. Immunol. Immunopathol., 1989; 51: 419-25.
100. Shah, A., Church, M. K., and Holgate, S. T., Tumor necrosis factor: A potential mediator of asthma, Clin. Exper: Allergy, 1995; 25: 1038-44.
101. Sueoka, N., Sueoka, E., Miyazaki, Y., Okabe, S., Kurosumi, M., Takayama, S., and Fujiki, H., Molecular pathogenesis of interstitial pneumonitis with TNF-α transgenic mice, Cytakine, 1998; 10: 124-31.
102. Kuschner, W. G., d'Allessandro, A., Wong, H., and Blanc, P. D., Early pulmonary cytokine responses to zinc oxide fume inhalation, Environ. Res., 1997; 75: 7-11.
103. Antonini, J, M., Krishna, M. G. G., and Brain, J. D., Responses to welding fumes: lung injury, inflammation and the release of tumor necrosis factor-α and interleukin-1β, Exp. Lung Res., 1997; 23: 20527.
104. Driscoll, K. E., Carter, J. M., Hassenbein, D. G., and Howard, B., Cytokines and particle-induced inflammatory cell recruitment, Environ. Hlth. Perspect., 1997; 5: 1159-64.
105. Arias-Diaz, J., Villa, N., Hernandez, J., Vara, E., and Balibrea, J. L., Carbon monoxide contributes to the cytokine-induced inhibition of surfactant synthesis by human type II pneumocytes, Arch. Surg., 1997; 132: 1352-60.
106. Sleijfer, S., Vujaskovic, Z., Limburg, P. C., Koops, H. S., and Mulder, N. H., Induction of tumor necrosis factor as a cause of bleomycin-related toxicity, Cancer, 1998,; 82: 970-4.
107. Bost, T. W., Riches, D. W., Schumacher, B., Carre, P. C., Khan, T. Z., Martinez, J. A., and Newman, L. S., Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor- and interleukin-6, but not interleukin-1α, Am. J. of Respr. Cell Mol. Biol., 1994; 10: 506-13.
108. Tinkle, S. S., Schwitters, P. W., and Newman, L. S., Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease, Environ. Hlth. Perspect., 1996; 104: 969-71.
109. Reinhart, P. G. and Gairola, C. G., Amiodarone-induced pulmonary toxicity in Fischer rats: release of tumor necrosis factor ́ and transforming growth factor β by pulmonary alveolar macrophages, J. Toxicol. Environ. Hlth., 1997; 52: 353-65.
110. Li, X. Y., Lamb, D., and Donaldson, K., The production of TNFα and IL-1-like activity by bronchoalveolar leukocytes after intratracheal instillation of crocilolite asbestos, Int. J. Exp. Pathol, 1993; 74: 403-11.
111. Simeonova, P.P. and Luster, M.I., Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-α (TNF-α) response from alveolar macrophages, Am. J. Respir. Cell Mol. Biol., 1995; 12: 676-83.
112. Vanhee, D., Gosset, P., Marquette, C. H., Wallaert, B., Lafitte, J. J., Gosselin, B., Voisin, C., and Tonnel, A. B., Secretion and mRNA expression of TNFα and IL-6 in the lungs of pneumoconiosis patients, Am. J. Respir. Crit. Care Med., 1995; 152: 298-306.
113. Jagielo, P. J., Watt, J. L., Quinn, T. J., Knapp, H. R., and Schwartz, D. A., Pentoxifylline does not alter the response to inhaled grain dust, Chest, 1997, 111: 1429-35.
114. Bost, T. W., Riches, D. W., Schumacher, B., Carre, P. C., Khan, T. Z., Martinez, J. A., and Newman, L. S., Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-α and interlieukin-6 but not interleukin-1β, Am. J. Respir. Cell Mol. Biol., 1994; 10: 506-13.
115. Ban, M., Hettich, D., Goutet, M., and Bonnet, P., TDI inhalation in guinea pigs involves migration of dendritic cells, Toxicol. Lett., 1997; 93: 185-94.
116. David, G. S., Pfeiffer, L. M., and Hemenway, D. R., Persistent overexpression of interleukin-1β and tumor necrosis factor-α in murine silicosis, J. Environ. Pathol. Toxicol. Oncol., 1998; 17: 99-114.
117. Driscoll, K. E., Hassenbein, D. G., Carter, J. M., Kunkel, S. L., Quinlan, T. R., and Mossman, B. T., TNFα and increased chemokine expression in rat lung after particle exposure, Toxicol. Lett., 1995; 82/83: 483-89.
118. Dong, W., Lewtas, J., and Luster, M. I., Role of endotoxin in tumor necrosis factor expression from alveolar macrophages treated with urban air particles, Exp. Lung Res., 1996; 22: 577-92.
119. Zelikoff, J. T., Parsons, E., and Schlesinger, R. B., Inhalation of particulate lead oxide disrupts pulmonary macrophage-mediated functions important for host defense and tumor surveillance in the lung, Environ. Res., 1993; 62: 207-22.
120. Ishii, Y., Yang, H., Sakamoto, T., Nomura, A., Hasegawa, S., Hirata, F., and Bassett, D. J., Rat alveolar macrophage cytokine production and regulation of neutrophil recruitment following acute ozone exposure, Toxicol. Appl. Pharmacol.. 1997; 147: 214-23.
121. Devlin, R. B., McKinnon, K. P., Noah, T., Becker, S., and Koren, H. S., Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells, Am. J. Physiol., 1994; 266: L612-9.
122. Pearson, A. C. and Bhalla, D. K., Effects of ozone on macrophage adhesion in vitro and epithelial and inflammatory responses in vivo: the role of cytokines, J. Toxicol. Environ. Hlth., 1997; 50: 143-57.
123. Huang, S., Paulauskis, J. D., Godleski, J. J., and Kobzik, L., Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation, Am. J. Pathol., 1992; 141: 981-8.
124. Vanhee, D., Gosset, P., Boitelle, A., Wallaert, B., and Tonnel, A. B., Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis, Eur. Respir. J., 1995; 8: 834-42.
125. Piguet, P. F., Grau, G. E., and Vassalli, P., Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries and epidermal cells, or massive tissue necrosis, Am J. Pathol., 1990; 136: 103-13.
126. Sime, P. J., Marr, R. A., Gauldie, D., Xing, Z., Hewlett, B. R., Graham, F. L., and Gauldie, J., Transfer of tumor necrosis factor-α to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-β 1 and myofibroblasts, Am. J. Pathol., 1998; 153: 825-32.
127. White, A. M., Yoshimura, T., Smith, A.W., Westwick, J., and Watson, M. L., Airway inflammation induced by recombinant guinea pig tumor necrosis factor-α, Am. J. Physiology, 1997; 273: 524-30.
128. Sueoka, N., Sueoka, E., Miyazaki, Y., Okabe, S., Kurosumi, M., Takayama, S., and Fujiki, H., Molecular pathogenesis of interstitial pneumonitis with TNF-α transgeneic mice, Cytokine, 1998; 10: 124-31.
129. Wong, G. H. W. and Goeddel, D. V., Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism, Science, 1988; 242: 941-4.
130. Dubaybo, B. A., Role of tumor necrosis factor-in regulating fibrotic lung repair, Res. Commun. Mol. Pathol. Pharmacol., 1998; 101: 69-79.
131. Ulrich, T., Yin, S., Remick, D., Russell, D., Eisenberg, S., and Kohno, T., Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation, Am. J. Pathol., 1993; 142: 1335-8.
132. Piguet, P. F., Collart, M. A., Grau, G. E., Sappino, A. P., and Vassalli, P., Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis, Nature, 1990; 344: 245-7.
133. Liu, J. Y., Brass, D. M., Hoyle, G. W., and Brody, A. R., TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers, Am. J. Pathol., 1998; 153: 1839-47.
134. Lander, H. M., An essential role for free radicals and derived species in signal transduction, FASEB J., 1997; 11: 118-24.
135. Baeuerle, P. A. and Baltimore, D., The physiology of the NF-κB transcription factor, in Molecular Aspects of Cellular Regulation: Hormonal Control regulation of Gene Transcription, Cohen, P. and Foulkes J. G., Eds., Elsevier, Amsterdam, 1991, 409-32.
136. Beutler, B. and van Huffel, C., An evolutionary and functional approach to the TNF receptor/ligand family, Annal. N.Y. Acad. Sci., 1994; 730: 118-33
137. Nickoloff, B., Karabin, G., Barker, J., Griffiths, C., Sarma, V., Mitra, R., Elder, J., Kunkel, S., and Dixit, V., Cytokine networks: immunobiology surfaces, J. NIH Res., 1991; 3: 71-3.
138. Kupper, T. S., Production of cytokines by epithelial tissues, Am. J. Dermatopathol., 1989; 11: 69-73.
139. Schroder, J. M., Cytokine networks in the skin, J. Invest. Dermatol., 1995; 105: 20-4.
140. Piguet, P.F., Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin, Springer Semin. Immunopathol., 1992; 13: 345-54.
141. Holliday, M. R., Corsini, E., Smith, S., Basketter, D. A., Dearman, R. J., and Kimber, I., Differential induction of cutaneous TNFα and IL-6 by topically applied chemicals, Am. J. Contact Derm., 1997; 8: 158-64.
142. Moller, H., Ohlsson, K., Linder, C., Bjorkner, B., and Braze, M., Cytokines and acute phase reactants during flare-up of contact allergy to gold, Am. J. Contact Derm., 1998; 9: 15-22.
143. Strickland, I., Rhodes, L. E., Flanagan, B. F., and Friedman, P. S., TNF and IL-8 are upregulated in the epidermis of normal human skin after UVB exposure: correlation with neutrophil accumulation and E-selectin expression, J. Invest. Dermatol., 1997; 108: 763-8.
144. Corsini, E., Terzoli, A., Bruccoleri, A., Marinovich, M., and Galli, C. L., Induction of TNF in vivo by a skin irritant, Tributyltin, through activation of transcription factors: Its pharmacological modulation by anti-inflammatory drugs, J. Invest. Dermatol., 1997; 108: 892-6.
145. Kondo, S. and Sauder, D. N., Tumor necrosis factor receptor type 1 (p55) is a main mediator for TNF-α-induced skin inflammation, Eur. J. Immunol., 1997; 27: 1713-8.
146. Luster, M. I., Wilmer, J. L., Germolec, D. R., Spalding, J., Yoshida, T., Gaido, K., Simeonova, P. P., Burleson, F. G., and Bruccoleri, A., Role of keratinocyte-derived cytokines in chemical toxicity, Toxicol. Lett., 1995; 82/83: 471-6.
147. Wood, L. C., Stadler, A. K., Liou, A., Campbell, I. L., Grunfeld, C., Elias, P. M., and Feingold, K. R., Barrier disruption increases gene expression of cytokines and the 55-kDa TNF receptor in murine skin, Exp. Dermatol., 1997; 6: 98-104.
148. Piguet, P. F., Grau, G. E., Hauser, C., and Vassalli, P., Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions, J. Exp. Med., 1991; 173: 673-9.
149. Lewis, R. W., McCall, J. C., Botham, P. A., and Kimber, I., Investigation of TNFα release as a measure of skin irritancy, Toxicol. In Vitro, 1993; 7: 393-5
150. Wang, B., Fujisawa, H., Zhuang, L., Kondo, S., Shivji, G., Kim, C. S., Mak, T. W., and Sauder, D. N., Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75, J. Immunol., 1997; 159: 6148-55.
151. Hoefakker, S., Caubo, M., Van't Erve, E. H. M., and Roggeveen, M. H., Goersma, W. J. A., Van Joost, T., Notten, W., and Claassen, E., In vivo cytokine profiles in allergic and irritant contact dermatitis, Contact Dermatitis, 1997; 33: 258-66.
152. Amar, S., Van Dyke, T. E., Eugster, H.-P., Schultze, N., Koebel, P., and Bleuthmann, H., Tumor necrosis factor-induced cutaneous necrosis is mediated by TNF receptor 1. J. Inflamm., 1995/6; 47:180-9.
153. Cumberbatch, M. and Kimber, T., TNFα is required for the accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization, Immunology, 1995; 84: 31-5.
154. Hubner, G., Brauchle, M., Smola, H., Madlener, M., Fassler, R., and Werner, S., Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice, Cytokine, 1996; 8: 548-56.
155. Hart, P. H., Grimbaldeston, M. A., Swift, G. J., Sedgwick, J. D., Korner, H., and Finlay-Jones, J. J., TNF modulates susceptibility to UVB-induced systemic immunomodulation in mice by effects on dermal mast cell prevalence, Eur. J. Immunol., 1998; 28: 2893-901.
156. Noonan, F. P., Bucana, C., Sauder, D. N., and DeFabo, E. C., Mechanism of systemic immune suppression by UV irradiation in vivo, J. Immunol., 1984; 132: 2408-16.
157. Wilson, A. G., de Vries, N., Poicot, F., di Giovine, F. S., van der Putte, L. B. A., and Duff, G. W., An allelic polymorphism within the human tumor necrosis factor promoter region is strongly associated with HLA A1, B8 and DR3 alleles, J. Exp. Med., 1993; 177: 557-60.
158. D'Alfonso, S. and Momigliano, R. P., A polymorphic variation in a putative regulation box of the TNF promoter region, Immunogenetics, 1994; 29: 150-4.
159. Arias, A. I., Giles, B., Eiermann, T. H., Sterry, W., and Pandey, J. P., Tumor necrosis factor-α gene polymorphism in psoriasis, Exp. Clin. Immunogenet, 1997; 14: 118-22.
160. Korman, K. S. and diGiovine, F. S., Genetic variations in cytokine expression: A risk factor for severity of adult periodontitis, Annal. Periodontol., 1998; 3: 327-38.
161. Zhai, R., Jetten, M., Schins, R. P. F., Franssen, H., and Borm, P. J. A., Polymorphisms in the promoter of the tumor necrosis factor-α gene in coal miners, Am. J. Industr. Med., 1998; 34: 318-24.
162. Seitzer, U., Swider, C., Stuber, F., Suchnicki, K., Lange, A., Richter, E., Zabel, P., Muller-Quernheim, J., Flad, H. D., and Gerdes, J., Tumor necrosis factor promoter gene polymorphism in sarcoidosis, Cytokine, 1997; 9: 787-90.